You are here:
Drugmakers
#Drugmakers
Get Alerts

Articles

View all

Uh oh.. is Ranbaxy in more trouble?

Jan 13, 2014

Uh oh.. is Ranbaxy in more trouble?

The US Food and Drug Administration (FDA) has raised concerns about the manufacturing practices at a factory owned by Ranbaxy Laboratories, the drugmaker said on Monday, sending its shares down to nearly a one-month low. #United States #Ranbaxy #Daiichi Sankyo #US FDA #drugmaker #Toansa
Largest PE investment in Indian pharma: KKR injects $200 mn into Gland Pharma

Nov 28, 2013

Largest PE investment in Indian pharma: KKR injects $200 mn into Gland Pharma

KKR'S latest investment in India underscores the positive outlook for generic drugmakers, despite some concerns about manufacturing quality after the recent crackdown by overseas regulators including the US Food and Drug Administration. #DealStream #Private equity #KKR #Pharma #drugmaker #Gland Pharma
US to hike fees for generic drugmakers from Oct; Indian firms to be hit

Aug 12, 2013

US to hike fees for generic drugmakers from Oct; Indian firms to be hit

Many Indian drugmakers will soon have to bear higher costs for sale of products in American markets, as the US health regulator FDA is hiking the fees for generic drugmakers by up to 48 percent from October. #United States #NewsTracker #US FDA #drugmaker #Indian drugmakers
Ranbaxy $500 mn fine: Why single out India and Ranbaxy?

Jun 05, 2013

Ranbaxy $500 mn fine: Why single out India and Ranbaxy?

Ranbaxy may be facing a potential ban on its generic drugs in United States but however Ranbaxy is not the only company that has faced such a crisis. #WhyNow #Ranbaxy Laboratories #US FDA #generic drugmakers
Ranbaxy's $500 mn settlement: All you need to know

May 14, 2013

Ranbaxy's $500 mn settlement: All you need to know

Ranbaxy will pay $500 mn to resolve fraud allegations that the company sold adulterated drugs and lied about it to US regulators. #US #CompanyWatch #Ranbaxy #Pharma #generic drugmakers

Wire

View all

Ranbaxy's $500 mn settlement: All you need to know

Jul 09, 2014

AbbVie forced to retract claims of Shire investor support

U.S. drugmaker AbbVie has been forced to retract comments by its chief executive about shareholder support for its $51 billion bid for Shire after being caught out by British takeover rules...
Ranbaxy's $500 mn settlement: All you need to know

Jul 08, 2014

AbbVie raises bid for drugmaker Shire to 51.15 pounds a share

U.S. drugmaker AbbVie raised its offer for Shire to 51...
Ranbaxy's $500 mn settlement: All you need to know

Jun 24, 2014

U.S. firm Abbott to buy Russian drugmaker for up to $495 mln

U.S. healthcare firm Abbott Laboratories is to buy Russian drugmaker Veropharm for up to $495 million, giving it a manufacturing presence in a country where it has been operating for nearly 40 years, Abbott said on Tuesday...